331 related articles for article (PubMed ID: 31250978)
21. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway.
Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L
Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin enhances growth inhibition on urothelial carcinoma cells through LKB1 deficiency-mediated mitochondrial dysregulation.
Whang YM; Kim MJ; Cho MJ; Yoon H; Choi YW; Kim TH; Chang IH
J Cell Physiol; 2019 Aug; 234(8):13083-13096. PubMed ID: 30549029
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of bromodomain-containing protein 4 enhances the migration of esophageal squamous cell carcinoma cells by inducing cell autophagy.
Yang WQ; Liang R; Gao MQ; Liu YZ; Qi B; Zhao BS
World J Gastrointest Oncol; 2022 Dec; 14(12):2340-2352. PubMed ID: 36568944
[TBL] [Abstract][Full Text] [Related]
24. BET bromodomain inhibitor JQ1 decreases CD30 and CCR4 expression and proliferation of cutaneous T-cell lymphoma cell lines.
Kamijo H; Sugaya M; Takahashi N; Oka T; Miyagaki T; Asano Y; Sato S
Arch Dermatol Res; 2017 Aug; 309(6):491-497. PubMed ID: 28593508
[TBL] [Abstract][Full Text] [Related]
25. Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
Hölscher AS; Schulz WA; Pinkerneil M; Niegisch G; Hoffmann MJ
Clin Epigenetics; 2018; 10():1. PubMed ID: 29312470
[TBL] [Abstract][Full Text] [Related]
26. The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Shahbazi J; Liu PY; Atmadibrata B; Bradner JE; Marshall GM; Lock RB; Liu T
Clin Cancer Res; 2016 May; 22(10):2534-44. PubMed ID: 26733615
[TBL] [Abstract][Full Text] [Related]
27. Sodium butyrate induces autophagy in colorectal cancer cells through LKB1/AMPK signaling.
Luo S; Li Z; Mao L; Chen S; Sun S
J Physiol Biochem; 2019 Feb; 75(1):53-63. PubMed ID: 30362049
[TBL] [Abstract][Full Text] [Related]
28. Vanadium(IV)-chlorodipicolinate alleviates hepatic lipid accumulation by inducing autophagy via the LKB1/AMPK signaling pathway in vitro and in vivo.
Huang Y; Liu F; Zhang F; Liu P; Xu T; Ding W
J Inorg Biochem; 2018 Jun; 183():66-76. PubMed ID: 29558683
[TBL] [Abstract][Full Text] [Related]
29. Probucol suppresses human glioma cell proliferation in vitro via ROS production and LKB1-AMPK activation.
Jiang YS; Lei JA; Feng F; Liang QM; Wang FR
Acta Pharmacol Sin; 2014 Dec; 35(12):1556-65. PubMed ID: 25399650
[TBL] [Abstract][Full Text] [Related]
30. TMP21 modulates cell growth in papillary thyroid cancer cells by inducing autophagy through activation of the AMPK/mTOR pathway.
Xu X; Gao H; Qin J; He L; Liu W
Int J Clin Exp Pathol; 2015; 8(9):10824-31. PubMed ID: 26617795
[TBL] [Abstract][Full Text] [Related]
31. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
[TBL] [Abstract][Full Text] [Related]
32. Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study.
Yu L; Shi Q; Jin Y; Liu Z; Li J; Sun W
BMC Cancer; 2021 Feb; 21(1):195. PubMed ID: 33632157
[TBL] [Abstract][Full Text] [Related]
33. Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells.
Zhou X; Chen Y; Wang F; Wu H; Zhang Y; Liu J; Cai Y; Huang S; He N; Hu Z; Jin X
Chem Biol Interact; 2020 Nov; 331():109273. PubMed ID: 33002460
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
Memmott RM; Gills JJ; Hollingshead M; Powers MC; Chen Z; Kemp B; Kozikowski A; Dennis PA
Cancer Res; 2008 Jan; 68(2):580-8. PubMed ID: 18199555
[TBL] [Abstract][Full Text] [Related]
35. Genistein-induced LKB1-AMPK activation inhibits senescence of VSMC through autophagy induction.
Lee KY; Kim JR; Choi HC
Vascul Pharmacol; 2016 Jun; 81():75-82. PubMed ID: 26924458
[TBL] [Abstract][Full Text] [Related]
36. The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma.
Bid HK; Phelps DA; Xaio L; Guttridge DC; Lin J; London C; Baker LH; Mo X; Houghton PJ
Mol Cancer Ther; 2016 May; 15(5):1018-28. PubMed ID: 26908627
[TBL] [Abstract][Full Text] [Related]
37. Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.
Zhu X; Enomoto K; Zhao L; Zhu YJ; Willingham MC; Meltzer P; Qi J; Cheng SY
Clin Cancer Res; 2017 Jan; 23(2):430-440. PubMed ID: 27440272
[TBL] [Abstract][Full Text] [Related]
38. The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.
Liu PY; Sokolowski N; Guo ST; Siddiqi F; Atmadibrata B; Telfer TJ; Sun Y; Zhang L; Yu D; Mccarroll J; Liu B; Yang RH; Guo XY; Tee AE; Itoh K; Wang J; Kavallaris M; Haber M; Norris MD; Cheung BB; Byrne JA; Ziegler DS; Marshall GM; Dinger ME; Codd R; Zhang XD; Liu T
Oncotarget; 2016 Nov; 7(48):79217-79232. PubMed ID: 27764794
[TBL] [Abstract][Full Text] [Related]
39. β-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy.
Hou T; Wang Y; Dan W; Wei Y; Liu B; Que T; Lei Y; Yu B; Zeng J; Fan Y; Li L
J Biochem Mol Toxicol; 2023 Jun; 37(6):e23331. PubMed ID: 36843289
[TBL] [Abstract][Full Text] [Related]
40. Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.
Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM
Mol Cancer Ther; 2016 Jun; 15(6):1217-26. PubMed ID: 26983878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
